8-K: Health Catalyst Appoints New CEO, Transitions Former CEO
Current Report (Form 8-K)
Health Catalyst, Inc. announced the appointment of Simeon Kohl as its new CEO and President, effective September 14, 2026, with Ben Albert transitioning to Chief Business Officer.
Summary
- Simeon Kohl has been appointed as the new Chief Executive Officer (CEO), President, and a member of the Board of Directors for Health Catalyst, Inc., effective September 14, 2026.
- Ben Albert, the current CEO, will transition to the role of Chief Business Officer and will step down from the Board of Directors effective September 13, 2026.
- Kohl brings extensive experience from his previous role as CEO of Performant Healthcare, where he led a significant transformation and its subsequent sale.
- Albert will continue to play a key role in advancing strategic priorities and working with Kohl and the leadership team.
- The company also adopted the Health Catalyst, Inc. 2026 Employment Inducement Incentive Plan to grant equity awards.
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a positive development, indicating a strategic leadership transition with a clear plan for continuity and future growth.
Positives
- Appointment of Simeon Kohl, a seasoned public-company healthcare leader with a strong track record in operational performance and shareholder value creation.
- Ben Albert's continued involvement as Chief Business Officer ensures continuity and leverages his deep understanding of the company's strategic priorities.
- The transition is described as a thoughtful decision, indicating a smooth and planned leadership change.
- Health Catalyst is positioned as an AI-forward healthcare intelligence company, with a focus on proprietary data and documented outcomes.
- The divestiture of Vitalware allowed the company to retire approximately $160 million in credit facility debt, strengthening its balance sheet.
Negatives
- The transition involves a change in top leadership, which can inherently introduce a period of adjustment.
- The company faces ongoing risks and uncertainties as disclosed in its SEC filings, including potential changes in laws, market conditions, client loss, and macroeconomic challenges.
Risks
- Changes in laws and regulations applicable to the business model.
- Changes in market or industry conditions, regulatory environment, and receptivity to technology and services.
- Results of litigation or a security incident.
- Loss of one or more key clients or partners, or clients reducing their spend.
- Fluctuations in project-based, non-recurring revenue.
- Macroeconomic challenges, natural disasters, or global conflicts.
- Potential adverse effects from the divestiture of Vitalware.
- Challenges in recruiting and retaining qualified team members.
Future Outlook
The company is positioning itself as an AI-forward healthcare intelligence company focused on driving stronger growth and operating performance. The appointment of Simeon Kohl is expected to build on existing strengths and proprietary data to achieve these goals. The company's outlook is subject to various risks and uncertainties disclosed in its SEC filings.
Management Comments
- "We're pleased to welcome Simeon Kohl to Health Catalyst. Simeon is a seasoned public-company healthcare leader with a strong track record of driving operational performance and creating shareholder value. The Board knows Simeon and his record well and engaged with him extensively in consideration for this role. We believe his experience, operating discipline, and leadership approach are particularly well suited to Health Catalyst and the opportunities ahead. We're also deeply grateful to Ben for the important work he has led and are pleased that he will continue as a key member of the leadership team."
- "I care deeply about Health Catalyst and this team, and I'm proud of what we have accomplished together. This was a thoughtful decision about what is best for the Company and me. I have confidence in Simeon and believe he is the right leader for what comes next."
- "I was drawn to Health Catalyst because it brings together two things I care deeply about: improving healthcare and building high-performing organizations. The company has an important mission, exceptionally talented people, and nearly two decades of proprietary data behind $2.8 billion in documented outcomes. The opportunity to build on those strengths to drive stronger growth and operating performance is what made this role so compelling to me."
Industry Context
StockSavvy.ai notes that the healthcare technology sector is increasingly focused on AI-driven solutions and measurable outcomes. Health Catalyst's positioning as an 'AI-forward healthcare intelligence company' aligns with this trend. The leadership transition at a critical juncture suggests a strategic move to accelerate growth and operational efficiency, a common theme among mature tech companies seeking to capitalize on evolving market demands.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Chief Executive Officer, President, Principal Executive Officer, Principal Operating Officer, and Director | Benjamin Albert | Simeon Kohl | September 14, 2026 | Succession planning and strategic leadership transition. |
| Chief Business Officer | N/A | Benjamin Albert | September 14, 2026 | Transition from CEO role to focus on business operations and strategic priorities. |
| Director (Class III) | Benjamin Albert | Simeon Kohl | September 14, 2026 | Appointment following Benjamin Albert's resignation from the Board. |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Adoption of Incentive Plan | Adoption of the Health Catalyst, Inc. 2026 Employment Inducement Incentive Plan, reserving 2,747,385 shares for equity awards, without stockholder approval, pursuant to Nasdaq Rules. | September 4, 2026 | Provides a framework for incentivizing new employees and key personnel through equity awards, aligning with Nasdaq's inducement award exceptions. |
| Indemnification Agreement | Simeon Kohl is expected to enter into the Company's standard form of indemnification agreement. | Effective September 14, 2026 | Standard practice to protect officers and directors from personal liability related to their corporate duties. |
Legal Proceedings
- No specific legal proceedings are detailed in this filing.
Related Party Transactions
- No direct or indirect material interest of Simeon Kohl in any transaction requiring disclosure under Item 404(a) of Regulation S-K is indicated.
Stakeholder Impact
- Shareholders: The transition is intended to drive stronger growth and operating performance, potentially leading to increased shareholder value. The equity grant to the new CEO is a standard incentive.
- Employees: The appointment of a new CEO with a strong leadership background may bring new strategic direction and operational focus. The continued role of Ben Albert may provide stability.
- Management Team: The transition requires alignment between the new CEO and the existing leadership team to execute strategic priorities.
- Creditors: The retirement of $160 million in debt strengthens the company's balance sheet, which is positive for creditors.
Next Steps
- Simeon Kohl to assume CEO, President, and Board member roles on September 14, 2026.
- Benjamin Albert to transition to Chief Business Officer role on September 14, 2026.
- Granting of restricted stock units to Simeon Kohl under the 2026 Employment Inducement Incentive Plan.
- Continued focus on advancing strategic priorities and driving growth and operating performance.
Key Dates
| Date | Description |
|---|---|
| September 4, 2026 | Date of Report (Date of earliest event reported); Board adopted the Health Catalyst, Inc. 2026 Employment Inducement Incentive Plan; Offer letters entered into for Simeon Kohl and Benjamin Albert. |
| September 8, 2026 | Date of Press Release announcing CEO transition. |
| September 13, 2026 | Effective date of Benjamin Albert's resignation as CEO, President, principal executive officer, principal operating officer, and member of the Board. |
| September 14, 2026 | Effective date of Simeon Kohl's appointment as CEO, President, principal executive officer, principal operating officer, and member of the Board; Effective date of Benjamin Albert's appointment as Chief Business Officer. |
Recommendation
holdThe filing announces a planned leadership transition with a focus on continuity and future growth, which is generally positive. However, without new financial performance data or significant strategic shifts beyond leadership changes, a 'hold' recommendation is prudent. Investors will likely await further performance updates under the new CEO to assess the impact on the company's trajectory.
Keywords
CEO Appointment, Leadership Transition, Healthcare Technology, Corporate Governance, Executive Officer, Board of Directors, Healthcare Intelligence, Strategic Priorities
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.